Key Highlights
- Medable launches Studio, a no-code suite for eCOA Plus.
- Streamlines complex eCOA launch process, reducing setup time from months to hours.
- Enables greater control, transparency, and faster patient enrollment.
- Includes innovative tools like Point-and-Click Builder and Translation Workbench.
Source: Business Wire
Notable Quotes
- “Medable Studio is where trial teams go to create. It allows for greater scalability, efficiency gains, and better, protocol-fit science. Studio will set new benchmarks for trial execution and ultimately advance our mission to enable effective therapies to reach patients faster by reducing trial start-up timelines and cost.” — Michelle Longmire, CEO and co-founder at Medable
- “Medable Studio upends the traditional study build/test/launch process by streamlining it using intelligence and automation. With Medable Studio, timelines shift from weeks and months to just days.” — Tim Smith, CTO and co-founder at Medable
SoHC's Take
Medable Studio represents a significant advancement in clinical trial technology, addressing long-standing bottlenecks in the eCOA process. By offering a no-code, user-friendly platform, Medable empowers pharmaceutical companies to accelerate trial timelines and improve cost efficiency. The ability to scale and customize trial processes with increased transparency and control positions Medable Studio as a disruptive force in the clinical trial industry. This innovation not only supports the rapid deployment of trials but also ensures that life-saving therapies reach patients faster, marking a pivotal shift in the future of clinical research.
